Catalyst Wire Dossier Catalyst Wire Dossier

Sofosbuvir/Velpatasvir/Voxilaprevir

sofosbuvir/velpatasvir/voxilaprevir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Sofosbuvir/Velpatasvir/Voxilaprevir, covering 2017-09-14 to 2022-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders [Phase 4]

See pricing